DrugPatentWatch Database Preview
Watson Labs Teva Company Profile
What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?
WATSON LABS TEVA has forty-nine approved drugs.
There is one tentative approval on WATSON LABS TEVA drugs.
Summary for Watson Labs Teva
| US Patents: | 0 |
| Tradenames: | 43 |
| Ingredients: | 41 |
| NDAs: | 49 |
Drugs and US Patents for Watson Labs Teva
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Teva | ATENOLOL | atenolol | TABLET;ORAL | 073353-001 | Dec 27, 1991 | DISCN | No | No | See Pricing | See Pricing | |||||
| Watson Labs Teva | SIMVASTATIN | simvastatin | TABLET;ORAL | 076685-001 | Dec 20, 2006 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Watson Labs Teva | ISRADIPINE | isradipine | CAPSULE;ORAL | 077317-002 | Jan 5, 2006 | AB | RX | No | Yes | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
